Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation (MV) for the treatment of respiratory failure. Its lead product is the augmented respiration technology system (ART), a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. The company was incorporated in 2018 and is based in Ra'annana, Israel.
Revenue of Inspira Technologies Oxy B.H.N. Ltd. (IINN)
Revenue in 2023 (TTM): $
According to Inspira Technologies Oxy B.H.N. Ltd.'s latest financial reports the company's current revenue (TTM) is $. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history of Inspira Technologies Oxy B.H.N. Ltd.
Annual Revenue
| Year | Revenue | Gross Profit | Ebitda | Income Before Tax | Net Income |
|---|---|---|---|---|---|
| 2023 | $ | $-406,000 | $-10,870,000 | $-11,286,000 | $-11,286,000 |
| 2022 | $-4,678,000 | $-5,039,000 | $-14,684,000 | $-10,273,000 | $-4,002,000 |
| 2021 | $ | $-218,000 | $-16,718,000 | $-16,955,000 | $-16,961,000 |
| 2020 | $ | $-203,000 | $-6,959,000 | $-7,228,000 | $-7,233,000 |
| 2019 | $ | $-76,000 | $-4,490,000 | $-4,575,000 | $-4,584,000 |
| 2018 | $ | $ | $ | $-39,600 | $-39,600 |